Jeanne  Thoma net worth and biography

Jeanne Thoma Biography and Net Worth

Director of ANI Pharmaceuticals
Ms. Thoma was appointed to the Board of Directors in December 2020.  Ms. Thoma is a seasoned pharmaceutical industry executive with more than 30 years of experience spanning product development and commercialization, as well as operations and supply chain management. She most recently served as president and chief executive officer of SPI Pharma Inc., a global pharmaceuticals ingredients company and an innovative solutions provider of ingredients and drug delivery systems. Prior to SPI, Ms. Thoma held positions of increasing responsibility at Lonza AG, a Switzerland-based biotech company, most recently as president and chief operating officer of the microbial control business sector. Before joining Lonza, she spent 14 years within the pharma solutions business at BASF Corporation, during which time she held various leadership positions in the areas of sales, marketing and operations. Ms. Thoma is a member of the board of advisors for the Drug Chemical and Associated Technologies Association (DCAT) and currently sits on the board of directors of ANI Pharmaceuticals and Nanoform.

How do I contact Jeanne Thoma?

The corporate mailing address for Ms. Thoma and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at [email protected]. Learn More on Jeanne Thoma's contact information.

Has Jeanne Thoma been buying or selling shares of ANI Pharmaceuticals?

Jeanne Thoma has not been actively trading shares of ANI Pharmaceuticals during the past quarter. Most recently, on Monday, December 20th, Jeanne Thoma bought 1,072 shares of ANI Pharmaceuticals stock. The stock was acquired at an average cost of $46.47 per share, with a total value of $49,815.84. Learn More on Jeanne Thoma's trading history.

Who are ANI Pharmaceuticals' active insiders?

ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Thomas Haughey (Director), Nikhil Lalwani (Pres), Muthusamy Shanmugam (Head of R&D and COO), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.

Are insiders buying or selling shares of ANI Pharmaceuticals?

During the last year, insiders at the specialty pharmaceutical company sold shares 39 times. They sold a total of 371,731 shares worth more than $23,601,729.53. The most recent insider tranaction occured on October, 14th when VP Meredith Cook sold 250 shares worth more than $14,297.50. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.

Information on this page was last updated on 10/14/2024.

Jeanne Thoma Insider Trading History at ANI Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021Buy1,072$46.47$49,815.84View SEC Filing Icon  
See Full Table

Jeanne Thoma Buying and Selling Activity at ANI Pharmaceuticals

This chart shows Jeanne Thoma's buying and selling at ANI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals logo
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Read More

Today's Range

Now: $56.91
Low: $55.99
High: $57.14

50 Day Range

MA: $58.31
Low: $55.10
High: $61.74

2 Week Range

Now: $56.91
Low: $48.20
High: $70.81

Volume

131,831 shs

Average Volume

282,775 shs

Market Capitalization

$1.20 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71